Aster Capital Management (Difc) LTD Summit Therapeutics Inc. Transaction History
Aster Capital Management (Difc) LTD
- $462 Billion
- Q3 2024
A detailed history of Aster Capital Management (Difc) LTD transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Aster Capital Management (Difc) LTD holds 197 shares of SMMT stock, worth $4,233. This represents 0.0% of its overall portfolio holdings.
Number of Shares
197Holding current value
$4,233% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding SMMT
# of Institutions
191Shares Held
75.8MCall Options Held
1.33MPut Options Held
2.39M-
Baker Bros. Advisors LP New York, NY24.4MShares$525 Million5.73% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.9MShares$235 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.9MShares$170 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.44MShares$117 Million0.01% of portfolio
-
State Street Corp Boston, MA3.47MShares$74.5 Million0.0% of portfolio
About Summit Therapeutics Inc.
- Ticker SMMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 201,215,008
- Market Cap $4.32B
- Description
- Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...